Intervention

Clopidogrel

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 24 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials24
Recruiting1
Common conditions25
Lead sponsors shown15
Advertisement

Clinical trials

24 shown
Clopidogrel Versus Cilostazol on VesselsNCT06402747 · 2024-04-16
RECRUITING
Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung CarcinomasNCT06872541 · 2025-01-20
ACTIVE_NOT_RECRUITING
Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusNCT04305587 · 2020-03-16
COMPLETED
Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.NCT04069234 · 2019-09-15
WITHDRAWN
Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes MellitusNCT03774394 · 2019-08-22
COMPLETED
Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCINCT03437044 · 2018-03-14
COMPLETED
Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mgNCT03329261 · 2017-12-07
COMPLETED
Effect of Diabetes and Hepatic Enzymes Mutation on Clopidogrel VS Ticagrelor Activity in Myocardial Infarction (MI) Patients Undergoing Primary Percutaneous Coronary Intervention (PCI)NCT03613857 · 2017-04-15
COMPLETED
A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial InfarctionNCT02663713 · 2017-01-01
COMPLETED
Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?NCT02983214 · 2016-11-01
COMPLETED
Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary InterventionNCT02748330 · 2016-06-01
COMPLETED
Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes MellitusNCT02548650 · 2016-03-25
COMPLETED
Targeting Platelets in Chronic HIV InfectionNCT02578706 · 2015-10-01
COMPLETED
ComparisoN of ticAgrelor vs. Clopidogrel in endoTHeliAl Function of COPD patieNtsNCT02519608 · 2015-09-01
COMPLETED
Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)NCT02457130 · 2015-04-01
UNKNOWN
Antiplatelet Therapy in HIVNCT02559414 · 2015-02-01
COMPLETED
Clopidogrel Versus Ticagrelor in Type-2 DiabetesNCT02742987 · 2014-03-01
COMPLETED
Effect of Clopidogrel on Allergen Challenge in AsthmaNCT01955512 · 2013-05-01
COMPLETED
VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to PrasugrelNCT01684813 · 2012-10-01
COMPLETED
Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic NephropathyNCT01743014 · 2012-07-01
UNKNOWN
Zainidip in Renal Artery StenosisNCT02594410 · 2011-09-01
COMPLETED
A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelNCT01263093 · 2010-12-01
COMPLETED
Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' StudyNCT02294643 · 2009-04-01
COMPLETED
Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)NCT00642174 · 2008-04-01
COMPLETED

Common conditions

Trial status mix

COMPLETED19
UNKNOWN2
ACTIVE_NOT_RECRUITING1
RECRUITING1
WITHDRAWN1

Phase mix

PHASE413
PHASE26
PHASE33
PHASE12
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.